Member Info for Bella6532

6.25m total trades since am 24 July.

Stoc looks ready to bounce up. Also at bottom of Bollinger Bands and again lined up for a bump up...

Sorry JoeSoap1 for typo...

JoeSosp1...'once P1a was complete and fully peer reviewed then they would publish all the findings to mainstream media.'

Peer review is key in the science world...however, it's pretty gutsy for EF to go on to state once fully peered reviewed they would publish all the findings to main stream media...that statement in itself should tell us how confident they are about getting a good review...

Hexwas with Clinigen.

https://avacta.com/director-appointment-2/

Clinigen was bought out and our new advisors facilitated the deal.

Remember AS's letter to the times in which he mentioned MiFID II...now we just need Hunt to pull his finger out and get it cancelled...tooti sweeti...

https://na.linkedin.com/posts/alastair-smith-1b4b9111_times-letters-30-jan-2023-activity-7025777741383770113-ixbg

'Small Cap Equities – Oversold but not under loved

We are in an environment where qood quality stocks are being sold down in preference to lesser quality companies as investors sell anything with liquidity

Last time it was this bad was April/May 2020 due to Covid and Summer/Autumn 2008 when Lehman Bros went bust

It gives free reign to the short sellers, whoever they are, though many will have been deleveraged by their lenders

Equities will be prone to increasingly volatile swings as value investors pick up bargains in this unexpectedly poor market environment

If the UK government allows insurers and pension funds, which hold just 4% of their assets directly in UK equities, to invest in into new startups and infrastructure projects this should make a dramatic difference to the market.

But, how quickly this occurs and how much funding will be made is another question.'

"MiFID II – UK government to boost investment in new startups and infrastructure projects and to reverse MiFID rules on research.

Jeremy Hunt, UK Finance Minister, is reported to be planning to allow insurers to invest billions of pounds into startups and infrastructure projects. (Boomberg)

The move may roll back some of the damaging legislation put in place by Gordon Brown whose puritanical policies seemed to think insurers and pension funds should invest mainly in bonds.

The move is said to follow a key recommendation of a review on investment research done by lawyer Rachel Kent.

Hunt is also reported to be planning to roll back legislation requiring investment banks to split the cost of research from trading expenditures.

MiFID II also included regulations requiring brokers to unbundle customer charges for research and order execution.'

Jive-turkey...and that's only AVA6000...what about the licencees we already have and their on going trials/research etc...what about affimers...what about our new companies...so much more coming down the tracks...

Start £55m

23 Jan After Qrtly Repayment = Balance £52.25

13 Feb After Conversion = Balance £49.40

21 Apr After Qrtly Repayment = Balance £46.80

No Conversion to date.

21 Jul Next Qrtly Repayment should reduce Balance to around £44,2m

Almostrich...'and there ain’t many companies on the planet have this and lots saying we want it'....mmmm! I wonder if that was a bit of slip...'lots saying they want it'....saying to who? I wonder if he should have said that or whether he just threw it in hoping some in the room might pick up on it...

Well worth a read...

https://consilium-comms.com/news-insights/consilium-conscience/consilium-conscience/2022/asco-bringing-mental-health-into-cancer-care/

I hope we see a media splurge as we move onto 1b...safety proven, therapeutic levels delivered directly into tumour with virtually no side effects etc etc...

Icecool...a great move by Avacta..the last lot were too much like gate keepers keeping everybody out. Hopefully this new lot will be more user friendly. Are we seeing the first step on the road to commercialisation...

Icecool...a great move by Avacta..the last lot were too much like gate keepers keeping everybody out. Hopefilly this new lot will be more user friendly. Are we seeing the first step in the road to ommercialisation...

'"anticipates strong news flow in the coming months from across the Group. “'

Across the Group...and remember the Group is now 2 companies bigger...

Checking...

'"Avacta has a strong cash balance of £27 million on its balance sheet as at 31 May (unaudited) and anticipates strong news flow in the coming months from across the Group. “'

If they just invest it at 4% they would make over £1m in 12 months. Sounds good but as a business they will be looking at much higher returns. Two companies purchased so far since the fundraise...who next or what next. All eyes seem to be focused on AVA6000 right now but it might be worth check your rear view mirror...

It isn't just about low blood cell counts cause by dox it's about the bodies inability often to fight off infections when they are at their low points which can then lead to all sorts of problems and in some cases death. Chemo is wicked on on sorts of levels and Dox is one of the worst. So if AVA6000 comes with no side effects AND doesn't damage blood cells AND doesn't damage other major organs AND it delivers a therapeutic level of Dox directly INTO the tumour cells then what's not to like about it. We are only at 1a (SAFETY ASSESSMENT) in the trial but already we know all about the aforementioned benefits...now we just need to find the MTD, move onto 1b (EFFICACY) confirmation and bingo...this point in time will be just a faint memory and those who stick it out will be wondering why they didn't spend more time doing other great things with their life rather than endlessly posting on a BB...go enjoy the sunshine guys...life's too short...

Smeeagain...I wonder if they will be pursuing through new customers/suppliers now part of the enlarged Avacta through the recent acquisitions. Covid is just one virus out there...surely we don't have to wait for another pandemic...

https://avacta.com/update-on-affimer-therapy-for-covid-19-infection/